We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Cardiac Troponin Diagnostics Market Driven by Demand for High Sensitivity POC Testing

By HospiMedica International staff writers
Posted on 27 Mar 2023
Print article
Image: North America is the leading region in the global cTn diagnostics market (Photo courtesy of Pexels)
Image: North America is the leading region in the global cTn diagnostics market (Photo courtesy of Pexels)

Cardiac troponin (cTn) biomarkers are commonly used by healthcare professionals to diagnose myocardial infarction (MI), and their popularity has led to an increasing demand for cTn diagnostics in emergency departments (EDs). To detect troponin at lower concentrations, hospitals and clinical laboratories are adopting high-sensitivity (hs) assays. The use of point-of-care testing (POCT) for cTn is also on the rise, particularly in EDs and remote locations, due to its ability to provide rapid results in a shorter period compared to lab-based tests. Furthermore, companies have developed high-sensitivity POCT cTn assays that provide accurate results within a few minutes.

The global market for cTn diagnostics is expected to achieve a compound annual growth rate (CAGR) of 2.4%, reaching USD 2.28 billion by 2025 from USD 2.07 billion in 2021. This growth will be fueled by a rise in the number of patients with cardiac complaints visiting EDs and the increasing adoption of hs-cTn assays by hospitals and clinical laboratories, which can detect troponin in lower concentrations and shorten the timeline for MI detection. North America is leading the global cTn diagnostics market, as hospitals and laboratories have started using high-sensitivity (hs) assays since receiving approval from the United States Food and Drug Administration in 2017. These are the latest findings of Frost & Sullivan (San Antonio, TX, USA), a business consulting and services company.

In the future, market players are expected to focus on developing quick and user-friendly diagnostic tests tailored to EDs, as shorter turnaround times in EDs can lead to substantial cost savings in healthcare. Investment in research and development of hs-cTn is likely to increase, as it can provide fast diagnostic results and lower the likelihood of false positives. The market is anticipated to witness the emergence of applications and software platforms that can integrate with devices, allowing for real-time data and improving the speed and effectiveness of the diagnostic process. Furthermore, there will be an increased emphasis on educating and empowering patients and clinicians about new diagnostic technologies and their proper use to prevent false positives.

"An increasing need for rapid and reliable cTn diagnostics tests in EDs to mitigate urgent response challenges for a positive test result is noticeable," said Utkarsha Kaustubh Soundankar, Healthcare Research Analyst at Frost & Sullivan. "The dynamics will boost the market revenue for POC tests during the forecast period."

"Point-of-care testing (POCT) is rapidly gaining traction globally and reduces turnaround time and the length of stay in the ED. Additionally, POC troponin assays can offer test results within 20 minutes, and doctors can use them for diagnosis in remote settings and the ED," Soundankar added.

Related Links:
Frost & Sullivan

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Orthopedic Extension
AMSCO

Print article

Channels

Surgical Techniques

view channel
Image: ImmersiveAR is an FDA-510(k) cleared augmented reality (AR) software (Photo courtesy of 123RF)

Breakthrough AR Surgical System Brings Precision-Enhanced Visualization into the OR

State-of-the-art mixed reality and artificial intelligence (AI) technologies are revolutionizing the field of surgery. Now, a groundbreaking augmented reality (AR) technology platform enables surgeons... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Business

view channel
Image: The finalists have been announced for the IHF Awards 2024 (Photo courtesy of IHF)

International Hospital Federation Awards 2024 Finalists Announced

The International Hospital Federation (IHF; Geneva, Switzerland) has announced the finalists of the IHF Awards 2024 after the judges completed scoring entries in all 7 Award categories. The IHF Awards... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.